Side-by-side financials for AUTL and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AUTL | RVMD |
|---|---|---|
| Market cap | - | $30.65 B |
| US-listed rank | - | #454 |
| Revenue (latest FY) | $75.39M | $0.00 |
| Net income (latest FY) | -$287.53M | -$1.13B |
| Net margin | -381.4% | - |
| SEC filings | 305 | 782 |
In their latest fiscal years, Autolus Therapeutics plc reported $75.39M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Autolus Therapeutics plc and Revolution Medicines, Inc., or browse the full rankings.